Keynote: How Lyndra Is Working to 'Reinvent Medicine for a Healthier World

Tuesday, October 18, 2022

1:30 PM – 2:30 PM ET

Location:206 AB

Manufacturing and Analytical Characterization

Moderator(s)

Maria Cruanes, PhD Chemistry (she/her/hers)

Director Analytical Chemistry
Organon
Spring House, Pennsylvania

Keynote Speaker(s)

Patricia Hurter, PhD (she/her/hers)

CEO
Lyndra Therapeutics Inc.
Wellington, Florida

Handouts

While biopharmaceutical companies have made tremendous advances, patients still struggle to adhere with their medication regimens and are challenged with medication access. In addition, daily pills do not deliver medicine in a pharmacologically optimized way. These barriers are particularly challenging when dealing with global health issues like malaria, safe contraception, and HIV prevention and treatment. An emerging new delivery platform may change all that by delivering long-acting oral therapies to optimize medication delivery and health outcomes, and potentially even enable the eradication of malaria. This presentation will review adherence challenges, shortcomings of the tried and true daily pills that are ubiquitous, and describe an innovative approach to drug delivery that addresses these challenges. The technology innovations required to make this a reality will be discussed.

Learning Objectives:

Upon completion, participants will be able to understand the importance for improving medication adherence and access
Upon completion, participants will be able to discuss the need for and potential of a new scientific innovation that can impact how people effectively take oral therapies
Upon completion, participants will be able to appreciate the value and impact of continuous manufacturing practices